Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting

As a surrogate marker for long-term complications of diabetes, glycated hemoglobin (HbA1c) is the “gold standard” metric used by clinicians in the management of people with diabetes [1–4]. However, as HbA1c is indicative of average glycemic control over approximately 2–4 months [2,4], it does not reflect fluctuations in blood glucose levels (i.e., glycemic variability). Glycemic variab ility is directly associated with micro- and macrovascular complications of diabetes [5,6], as well as short-term risks of hypoglycemia [6,7].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research